Two Different Faces from Unicentric Castleman Disease (UCD): A Case Series

Mehrdad Payandeh¹, Afshin Karami² and Noorodin Karami^3,

¹Department of Hematology and Medical Oncology, Kermanshah University of Medical Sciences, Kermanshah, Iran

²Department of Hematology, Shahid Beheshti University of Medical Sciences, Tehran, Iran

³Department of Genetic, Shahid Sadoughi University of Medical Sciences, Yazd, Iran

Cite this paper:
Mehrdad Payandeh, Afshin Karami and Noorodin Karami. Two Different Faces from Unicentric Castleman Disease (UCD): A Case Series. American Journal of Cancer Prevention. 2017; 5(3):37-38. doi: 10.12691/ajcp-5-3-3

Abstract

Castleman disease is a rare lymphoproliferative disorder that was first reported in 1954. The most common type is unicentric and is a benign form of lymphatic disorders, which its treatment has been successfully reported. The etiology of this disease is still unclear, but there is a relationship between this disorder and overproduction of IL- 6. In our study, after treating one of the patients with UCD, due to the unexpected transformation of this disease to DLBCL, the new treatment was performed with combination chemotherapy and is still ongoing. We suggest continuous follow-up of patients during and after treatment. As well, more investigations are needed on the pathogenesis of disease that will lead to better treatment for these patients.

Keywords:
castleman disease unicentric DLBCL lymphoproliferative

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]	Xie H, Zhou S, Deng C, Jiao J, Fan C, Zhang Y. Case report: Castleman’s disease in trachea. BJR| case reports. 2017:20160063.
[2]	Uysal B, Demiral S, Gamsiz H, Dincoglan F, Sager O, Beyzadeoglu M. Castleman's disease and radiotherapy: A single center experience. Journal of cancer research and therapeutics. 2015; 11(1): 170.
[3]	El-Osta HE, Kurzrock R. Castleman's disease: from basic mechanisms to molecular therapeutics. The oncologist. 2011; 16(4): 497-511.
[4]	Linkhorn H, van der Meer G, Gruber M, Mahadevan M. Castleman's disease: An unusually young presentation resulting in delayed diagnosis of a neck mass. International journal of pediatric otorhinolaryngology. 2016; 86: 90-2.
[5]	Van den Berge M, Pauwels P, Jakimowicz J, Creemers G. Hyaline vascular Castleman’s disease: a case report and brief review of the literature. Neth J Med. 2002; 60(11): 444-7.
[6]	Stebbing J, Pantanowitz L, Dayyani F, Sullivan RJ, Bower M, Dezube BJ. HIV‐associated multicentric Castleman's disease. American journal of hematology. 2008; 83(6): 498-503.
[7]	Martelli M, Ferreri AJ, Agostinelli C, Di Rocco A, Pfreundschuh M, Pileri SA. Diffuse large B-cell lymphoma. Critical reviews in oncology/hematology. 2013; 87(2): 146-71.
[8]	Payer E, Miltenyi Z, Simon Z, Magyari F, Barna S, Mehes G, et al. Diagnostic and Therapeutic Difficulties in Diffuse Large B-cell Lymphoma Arising From HHV8 Positive Castleman Disease. Journal of Hematology. 2012; 1(2-3): 65-9.
[9]	Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, et al. A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis. Acta Medica Iranica. 2017; 55(4): 276-8.
[10]	Abdessayed N, Bdioui A, Ammar H, Gupta R, Mhamdi N, Guerfela M, et al. Retroperitoneal unicentric Castleman’s disease: A case report. International journal of surgery case reports. 2017; 31: 54-7.
[11]	Gomez-Ramirez J, Posada M, Sanchez-Urdazpal L, Martin-Perez E, Del Campo L, Garcia I, et al. Castleman's Disease: A Case Report of the Unicentric Type. Case reports in surgery. 2012; 2012.
[12]	Bracale U, Pacelli F, Milone M, Bracale UM, Sodo M, Merola G, et al. Laparoscopic treatment of abdominal unicentric castleman’s disease: a case report and literature review. BMC surgery. 2017; 17(1): 38.
[13]	Chan K-L, Lade S, Prince HM, Harrison SJ. Update and new approaches in the treatment of Castleman disease. Journal of blood medicine. 2016; 7: 145.
[14]	Wong R. Management of Castleman’s Disease: Recent Advances and Case Sharing. 2012.
[15]	Casper C. The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. British journal of haematology. 2005; 129(1): 3-17.